DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...

Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...

Affordability is top of mind for executives at AHIP as Americans battle skyrocketing healthcare costs. “We are laser-focused on affordability at AHIP,” said Mike Tuffin, president and CEO of AHIP.

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

As AI technology in healthcare becomes more deeply involved in the complex, high-stakes tasks of diagnosis and treatment ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

The question is whether these AI tools will be another fragmented layer of technology or true assistants to help them spend ...

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...